First Bank & Trust Decreases Position in Zoetis Inc (ZTS)

First Bank & Trust trimmed its holdings in Zoetis Inc (NYSE:ZTS) by 11.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,475 shares of the company’s stock after selling 1,471 shares during the quarter. First Bank & Trust’s holdings in Zoetis were worth $1,155,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of ZTS. Vanguard Group Inc. increased its stake in Zoetis by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 35,947,496 shares of the company’s stock valued at $3,291,353,000 after purchasing an additional 293,614 shares in the last quarter. Vanguard Group Inc increased its stake in Zoetis by 0.8% during the 3rd quarter. Vanguard Group Inc now owns 35,947,496 shares of the company’s stock valued at $3,291,353,000 after purchasing an additional 293,614 shares in the last quarter. Oregon Public Employees Retirement Fund increased its stake in Zoetis by 9,042.7% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 14,335,563 shares of the company’s stock valued at $168,000 after purchasing an additional 14,178,765 shares in the last quarter. Polen Capital Management LLC increased its stake in Zoetis by 1.9% during the 4th quarter. Polen Capital Management LLC now owns 9,553,567 shares of the company’s stock valued at $817,212,000 after purchasing an additional 178,893 shares in the last quarter. Finally, FMR LLC increased its stake in Zoetis by 209.7% during the 4th quarter. FMR LLC now owns 7,245,748 shares of the company’s stock valued at $619,801,000 after purchasing an additional 4,905,887 shares in the last quarter. Institutional investors own 90.93% of the company’s stock.

In other Zoetis news, insider Roxanne Lagano sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $101.89, for a total transaction of $203,780.00. Following the sale, the insider now owns 30,727 shares in the company, valued at approximately $3,130,774.03. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Clinton A. Jr. Lewis sold 6,125 shares of the firm’s stock in a transaction that occurred on Thursday, February 14th. The stock was sold at an average price of $91.96, for a total transaction of $563,255.00. Following the sale, the insider now owns 45,512 shares in the company, valued at approximately $4,185,283.52. The disclosure for this sale can be found here. In the last three months, insiders sold 404,209 shares of company stock worth $38,052,349. 0.35% of the stock is currently owned by insiders.

ZTS has been the subject of a number of analyst reports. Zacks Investment Research lowered shares of Zoetis from a “hold” rating to a “sell” rating in a research note on Monday, February 4th. UBS Group initiated coverage on shares of Zoetis in a research note on Wednesday, January 23rd. They set a “neutral” rating and a $86.00 price objective for the company. Stifel Nicolaus upgraded shares of Zoetis from a “hold” rating to a “buy” rating and raised their price objective for the company from $97.00 to $110.00 in a research note on Monday, March 4th. SunTrust Banks initiated coverage on shares of Zoetis in a research note on Tuesday, March 19th. They set a “hold” rating and a $100.00 price objective for the company. Finally, BMO Capital Markets raised their price objective on shares of Zoetis from $93.00 to $101.00 and gave the company a “market perform” rating in a research note on Monday, February 25th. Six analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $100.57.

Shares of NYSE ZTS traded up $0.02 during trading on Monday, reaching $101.69. 14,530 shares of the company traded hands, compared to its average volume of 1,884,614. The company has a quick ratio of 2.46, a current ratio of 3.60 and a debt-to-equity ratio of 2.95. The company has a market cap of $48.43 billion, a PE ratio of 32.50, a PEG ratio of 1.83 and a beta of 0.93. Zoetis Inc has a 52-week low of $77.00 and a 52-week high of $103.33.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, February 14th. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.77 by $0.02. The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.53 billion. Zoetis had a net margin of 24.51% and a return on equity of 73.85%. The firm’s revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.69 earnings per share. As a group, equities research analysts anticipate that Zoetis Inc will post 3.46 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 3rd. Investors of record on Thursday, April 18th will be issued a $0.164 dividend. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Wednesday, April 17th. Zoetis’s payout ratio is 21.09%.

COPYRIGHT VIOLATION WARNING: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2019/04/15/first-bank-trust-decreases-position-in-zoetis-inc-zts.html.

About Zoetis

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

See Also: What is the price-to-earnings growth (PEG) ratio?

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply